Menu Search
Equities

Biosino Bio-Technology and Science Inc

8247:HKG.HZ

Biosino Bio-Technology and Science Inc

Actions
  • Price (HKD)0.85
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-19.81%
  • Beta--
Data delayed at least 15 minutes, as of May 28 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION is a China-based company principally engaged in the research and development, manufacture, sales and distribution of in-vitro diagnostics reagent products. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.

  • Revenue in HKD (TTM)311.82m
  • Net income in HKD-12.56m
  • Incorporated1988
  • Employees537.00
  • Location
    Biosino Bio-Technology and Science IncChangping Business Hotel Opposite,No.27,Chaoqian Road, Science and TechnologyIndustrial Park, Changping DistrictBEIJING 102200ChinaCHN
  • Phone+86 1 080117700
  • Fax+86 1 080117026
  • Websitehttps://www.zhongsheng.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.